<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05076773</url>
  </required_header>
  <id_info>
    <org_study_id>32900654326</org_study_id>
    <nct_id>NCT05076773</nct_id>
  </id_info>
  <brief_title>TPVB, PECSB, ESPB for Postmastectmy Pain</brief_title>
  <acronym>RCT</acronym>
  <official_title>A Comparative Study Between Ultrasound-guided Thoracic Paravertebral Block, Pectoral Nerves Block, and Erector Spinae Block for Pain Management in Cancer Breast Surgeries. A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menoufia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menoufia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the work The aim of the study is to compare between the effects of ultrasound guided&#xD;
      thoracic paravertebral block, pectoral nerve block II, and erector spinae block in management&#xD;
      of pain during cancer breast surgeries. The hypothesis of the study is that the three groups&#xD;
      will give comparative results.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2019</start_date>
  <completion_date type="Actual">August 10, 2021</completion_date>
  <primary_completion_date type="Actual">August 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome of the study will be duration of analgesia (time to first rescue analgesia after administration of the block).</measure>
    <time_frame>0-24o minutess</time_frame>
    <description>minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>assessed by VAS score (0-10) where 0=no pain and 10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>recorded postoperatively in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV)</measure>
    <time_frame>48 hours</time_frame>
    <description>4 points score of PONV (0-3) where 0=no PONV and 3=vomiting more than once</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Control Group (D)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient will receive opioid only for management of their perioperative pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paravertebral block Group (A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive thoracic paravertebral block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pectoral block Group (B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive pectoral 1 and 2 block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector spinae block Group (C)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive erector spinae block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound guided block</intervention_name>
    <description>Giving one regional block</description>
    <arm_group_label>Erector spinae block Group (C)</arm_group_label>
    <arm_group_label>Paravertebral block Group (A)</arm_group_label>
    <arm_group_label>Pectoral block Group (B)</arm_group_label>
    <other_name>Us guided paravertebral block</other_name>
    <other_name>Us guided erector spinae block</other_name>
    <other_name>Us guided PECs 1 and 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV morphine</intervention_name>
    <description>given when VAS&gt;3</description>
    <arm_group_label>Control Group (D)</arm_group_label>
    <arm_group_label>Erector spinae block Group (C)</arm_group_label>
    <arm_group_label>Paravertebral block Group (A)</arm_group_label>
    <arm_group_label>Pectoral block Group (B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ASA physical status classification class I or II&#xD;
&#xD;
          2. Age group 18 - 60 years of the female gender&#xD;
&#xD;
          3. Patients undergoing breast cancer surgeries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient refusal&#xD;
&#xD;
          2. History of hypersensitivity to local anesthetics&#xD;
&#xD;
          3. Bleeding disorders or patients receiving anticoagulants&#xD;
&#xD;
          4. Spine or chest wall deformities&#xD;
&#xD;
          5. Pregnancy&#xD;
&#xD;
          6. Local infection at the site of injection.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kareem M mikhimer, m.sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>assistant fellow, Ahmed Maher Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Menofia University</name>
      <address>
        <city>ShibÄ«n Al Kawm</city>
        <state>Menofia</state>
        <zip>32511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Menoufia University</investigator_affiliation>
    <investigator_full_name>kareem Mikhamer</investigator_full_name>
    <investigator_title>Assistant fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Title only</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

